CD7 and neoplasm: The anti-CD7 immunotoxin significantly inhibits the proliferation of T-cell acute lymphoblastic leukemia cells and extends the survival time of mice in a tumor transplant model and patient tumor-derived xenograft model by exerting a cytotoxicity function via endocytosis into the cytoplasm of CD7-positive cells.